Fig. 8
From: Human amnion cells reverse acute and chronic pulmonary damage in experimental neonatal lung injury
BASC and AT2 cells in neonatal mouse lungs at PND7 and PND14 (n = 6–8). a, b Average number of BASCs per terminal bronchiole on PND7 (a) and PND14 (b). There was no difference in the average number of BASCs per terminal bronchiole on PND7. This number was increased by early hAEC treatment, although there was no difference in late treatment group and injured groups on PND14. c, d Percentage of AT2 cells on PND7 (c) and PND14 (d). There was no difference in the percentage of AT2 cells between groups at both time points. Data expressed as mean ± standard error of mean (SEM). Statistical significance determined with one-way ANOVA accompanied by the Bonferroni post-hoc test. **p < 0.01. AT2s type II alveolar cells, BASC bronchioalveolar stem cell, hAEC human amnion epithelial cell